Abstract
The author provides an analysis of the study published by Agrawal and colleagues, in this issue of Journal of Diabetes Science and Technology, which describes usage and effectiveness of the low glucose suspend feature that is integrated into the Medtronic Paradigm® Veo™ sensor-augmented pump system.
References
1.
Agrawal
P
Welsh
JB
Kannard
B
Askari
S
Yang
Q
Kaufman
FR
. Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump . J Diabetes Sci Technol.
2011 ;5 (5 ): 1137 –41 .
2.
Danne
T
Remus
K
Blasig
S
Holder
M
Wadien
T
Haberland
H
Golembowski
S
Zierow
S
Hartmann
R
Thomas
A
. The low glucose suspend function in sensor-augmented pump therapy prevents hypoglycemia in children . American Diabetes Association 71st Scientific Session, San Diego, CA, 2011 .
3.Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group ,
Tamborlane
WV
Beck
RW
Bode
BW
Buckingham
B
Chase
HP
Clemons
R
Fiallo-Scharer
R
Fox
LA
Gilliam
LK
Hirsch
IB
Huang
ES
Kollman
C
Kowalski
AJ
Laffel
L
Lawrence
JM
Lee
J
Mauras
N
O'Grady
M
Ruedy
KJ
Tansey
M
Tsalikian
E
Weinzimer
S
Wilson
DM
Wolpert
H
Wysocki
T
Xing
D
. Continuous glucose monitoring and intensive treatment of type 1 diabetes . N Engl J Med.
2008 ;359 (14 ): 1464 –76 .